155 related articles for article (PubMed ID: 2958853)
1. Treatment of advanced carcinoma of the prostate by LHRH-agonists.
Claes HI; Vandenbussche L; Vereecken RL
Prog Clin Biol Res; 1987; 243A():229-37. PubMed ID: 2958853
[No Abstract] [Full Text] [Related]
2. [Treatment of advanced cancer of the prostate using LHRH analogs. How can a possible initial flare-up be prevented?].
Bouffioux C; Denis L; Mahler C; de Leval J
Acta Urol Belg; 1986; 54(3):304-8. PubMed ID: 2946208
[No Abstract] [Full Text] [Related]
3. Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Moffat LE
Eur Urol; 1990; 18 Suppl 3():26-7. PubMed ID: 2151272
[No Abstract] [Full Text] [Related]
4. Treatment of advanced prostatic cancer with LHRH-analogues. Prevention of "flare-up" phenomenon.
Bouffioux C; Denis L; Mahler C; de Leval J
Prog Clin Biol Res; 1987; 243A():255-60. PubMed ID: 2958857
[No Abstract] [Full Text] [Related]
5. LHRH-analogues therapy for metastatic prostate cancer.
Debruyne FM; Fernandez del Moral P; Geboers AD
Prog Clin Biol Res; 1988; 260():27-39. PubMed ID: 2966406
[No Abstract] [Full Text] [Related]
6. Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.
Paisey RB; Kadow C; Bolton C; Hartog M; Gingell JC
J R Soc Med; 1986 Apr; 79(4):210-1. PubMed ID: 2939240
[TBL] [Abstract][Full Text] [Related]
7. Treatment of prostatic cancer by monthly injections of an LHRH-analogue depot.
Hjertberg H; Varenhorst E; Svensson M; Kågedal B; Nordenskjöld B
Acta Oncol; 1988; 27(4):361-4. PubMed ID: 2974290
[TBL] [Abstract][Full Text] [Related]
8. [A 79-year-old man with metastatic prostate cancer, treated with Zoladex, flutamide, calcitonin and Ostac, suffers from frequent troublesome sweating with palpitation and angina pectoris, especially at night. Is there a therapy?].
Schmeller N
Internist (Berl); 1992 Apr; 33(4):284. PubMed ID: 1535344
[No Abstract] [Full Text] [Related]
9. Rapid rise of serum testosterone following discontinuation of long term treatment of prostate carcinoma with an LHRH-agonist.
Kreis W; Budman DR; Delli Bovi P; Vinciguerra V
Onkologie; 1988 Dec; 11(6):292-3. PubMed ID: 2977219
[No Abstract] [Full Text] [Related]
10. The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Allen JM; Williams G; O'Shea JP; Smith C; Yeo T; Kerle D; Bloom SR
Urol Res; 1984; 12(5):249-51. PubMed ID: 6240150
[TBL] [Abstract][Full Text] [Related]
11. [LHRH agonists combined with antiandrogens in the treatment of metastasizing prostatic carcinoma].
Senn E; Müller J; Alioth H
Schweiz Rundsch Med Prax; 1985 Nov; 74(48):1340-4. PubMed ID: 3003863
[No Abstract] [Full Text] [Related]
12. Influence of LH-RH agonists on the growth and hormonal environment of breast and prostate cancer.
Nicholson RI; Walker KJ
Chemioterapia; 1985 Jun; 4(3):249-51. PubMed ID: 3161643
[TBL] [Abstract][Full Text] [Related]
13. Results obtained in the treatment of prostate cancer patients with Zoladex.
Williams G; Kerle DJ; Roe SM; Yeo T; Bloom SR
Prog Clin Biol Res; 1985; 185A():287-95. PubMed ID: 3162175
[No Abstract] [Full Text] [Related]
14. Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Debruyne FM
Am J Clin Oncol; 1988; 11 Suppl 1():S33-5. PubMed ID: 2968760
[TBL] [Abstract][Full Text] [Related]
15. Treatment of locally advanced prostatic carcinoma with LHRH analogues: cytological, DNA-cytophotometrical, and clinical results.
Borgmann V; al-Abadi H; Nagel R
Am J Clin Oncol; 1988; 11 Suppl 1():S19-28. PubMed ID: 2968759
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced prostatic carcinoma with a slow release depot LHRH analogue (Zoladex depot).
Lukkarinen O; Kontturi M
Scand J Urol Nephrol Suppl; 1988; 110():109-12. PubMed ID: 2973121
[TBL] [Abstract][Full Text] [Related]
17. Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study.
Di Silverio F; Serio M; D'Eramo G; Sciarra F
Eur Urol; 1990; 18 Suppl 3():54-61. PubMed ID: 2151278
[TBL] [Abstract][Full Text] [Related]
18. Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
Di Silverio F; Sciarra F; D'Eramo G
Eur Urol; 1990; 18(1):10-5. PubMed ID: 2144819
[TBL] [Abstract][Full Text] [Related]
19. Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
Schulze H; Senge T
J Urol; 1990 Oct; 144(4):934-41. PubMed ID: 2144596
[TBL] [Abstract][Full Text] [Related]
20. [LHRH analogs--new possibilities in the treatment of prostatic cancer].
Baranowska B
Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):1009-12. PubMed ID: 6239145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
